AMIX

Autonomix Medical, Inc.

$1.85

8.82%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

Source: Yahoo Finance
AI summary

Price & performance

1M-30.9%
3M-42.2%
YTD-74.8%
1Y-87.8%
52-week range—
Beta1.79
Full chart and returns against a benchmark

Q-Score

11/ 100

Quality against peers; 50 is the peer median.

Growth—
Risk15
Performance30
Valuation12
Profitability4
Leverage63
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue—
Net income-$16.7M
Net margin—
Historical fundamentals

Red flags in filings

3active red flags
Going-concern doubtMay 27, 2026
Material weakness in controlsMay 27, 2026
Exchange listing noticeJan 16, 2026
Filings, findings and the timeline

Valuation

AMIXIndustryP/E—29.61P/S—3.49EV/EBITDA—18.38P/B1.153.39PEG——
Dividend yield0.00%
Every valuation metric